| Janssen-Cilag AG - Rybrevant SC 1600 mg/10 ml, Injektionslösung | | 69839 | | 01 | | Rybrevant SC 1600 mg/10 ml | | Injektionslösung | | L01FX18 | | Amivantamab | | 28.01.2026 | | |
| | Composition | | amivantamabum 1600 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 6.19 mg. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 1600mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Amivantamabum | 1600 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Dinatrii Edetas | | Hyaluronidasum Humanum Adnr | | Methionine | | Natrii Acetas Trihydricus | | Polysorbatum 80 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3538.02 | 3864.25 | A | SL | No |
|
|
